Coenzyme Q10 in Relation of the Lipid Peroxidation, Antioxidant Enzyme Activities in Coronary Artery Disease Patients
Launched by TAICHUNG VETERANS GENERAL HOSPITAL · Jul 14, 2010
Trial Information
Current as of May 04, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • CAD patients is identified by cardiac catheterization as having at least 50% stenosis of one major coronary artery
- Exclusion Criteria:
- • age \< 18 years old
- • pregnancy women
- • taking lowering lipid drug (Statin)
About Taichung Veterans General Hospital
Taichung Veterans General Hospital is a leading medical institution in Taiwan, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital leverages its extensive expertise in various medical fields to facilitate the development of new therapies and improve patient outcomes. With a focus on patient-centered care and adherence to rigorous ethical standards, Taichung Veterans General Hospital plays a pivotal role in bridging the gap between research and clinical practice, fostering collaborations that contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taichung, , Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials